Stock ALERS EUROBIO SCIENTIFIC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Eurobio Scientific

Equities

ALERS

FR0013240934

Biotechnology & Medical Research

Market Closed - Euronext Paris
Other stock markets
 11:35:22 2024-04-26 am EDT 		5-day change 1st Jan Change
14.28 EUR -1.11% Intraday chart for Eurobio Scientific -4.16% -13.24%
Apr. 11 Eurobio Scientific: 2023 results down, share price falls CF
Jan. 30 Eurobio Scientific Société anonyme acquired Alpha Biotech Ltd. CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 30.33 51.17 191.9 292.3 220.9 146 146 -
Enterprise Value (EV) 1 43.5 62.81 156.1 205.6 243 154.8 136.1 113.1
P/E ratio - - - - 8.38 x 33.2 x 15 x 11.8 x
Yield - - - - - - - -
Capitalization / Revenue 0.6 x 0.87 x 1.02 x 1.59 x 1.45 x 1.12 x 1.06 x 0.98 x
EV / Revenue 0.86 x 1.06 x 0.83 x 1.12 x 1.59 x 1.19 x 0.99 x 0.76 x
EV / EBITDA 5.59 x 8.97 x 1.77 x - 6 x 5.67 x 4.68 x 3.46 x
EV / FCF -20.2 x 18.5 x 2.97 x 3.21 x 6.04 x 6.17 x 7.02 x 4.79 x
FCF Yield -4.95% 5.41% 33.7% 31.2% 16.6% 16.2% 14.3% 20.9%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 9,896 10,910 11,324 10,857 10,848 10,224 10,224 -
Reference price 2 3.065 4.690 16.95 26.92 20.36 14.28 14.28 14.28
Announcement Date 4/17/19 4/14/20 4/29/21 4/6/22 4/5/23 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 50.4 59.1 188.9 184.1 152.6 130.6 138 148.4
EBITDA 1 7.781 7 88.2 - 40.5 27.3 29.1 32.7
EBIT 1 1.6 3.4 84 72.9 30.87 22.5 25.3 28.8
Operating Margin 3.17% 5.75% 44.47% 39.6% 20.23% 17.23% 18.33% 19.41%
Earnings before Tax (EBT) - - - - - - - -
Net income 1 -2.8 - 73.5 - 24.94 6 9.8 11
Net margin -5.56% - 38.91% - 16.34% 4.59% 7.1% 7.41%
EPS 2 - - - - 2.430 0.4300 0.9500 1.210
Free Cash Flow 1 -2.151 3.398 52.63 64.07 40.24 25.1 19.4 23.6
FCF margin -4.27% 5.75% 27.86% 34.8% 26.37% 19.22% 14.06% 15.9%
FCF Conversion (EBITDA) - 48.54% 59.68% - 99.36% 91.94% 66.67% 72.17%
FCF Conversion (Net income) - - 71.61% - 161.36% 418.33% 197.96% 214.55%
Dividend per Share - - - - - - - -
Announcement Date 4/17/19 4/14/20 4/29/21 4/6/22 4/5/23 - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 13.2 11.6 - - 22.1 8.8 - -
Net Cash position 1 - - 35.8 86.7 - - 9.9 32.9
Leverage (Debt/EBITDA) 1.692 x 1.663 x - - 0.5465 x 0.3223 x - -
Free Cash Flow 1 -2.15 3.4 52.6 64.1 40.2 25.1 19.4 23.6
ROE (net income / shareholders' equity) - - 103% - 14.9% 7.3% 9.9% 10.8%
ROA (Net income/ Total Assets) - - 58% - 9.23% 3.9% 5.3% 5.9%
Assets 1 - - 126.7 - 270.3 153.8 184.9 186.4
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 - - - - 2.83 2.2 3 3
Capex / Sales - - - - 1.86% 1.68% 2.17% 2.02%
Announcement Date 4/17/19 4/14/20 4/29/21 4/6/22 4/5/23 - - -
1EUR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Eurobio Scientific

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
14.28 EUR
Average target price
30 EUR
Spread / Average Target
+110.08%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
EUROBIO SCIENTIFIC Stock Eurobio Scientific
-13.24% 156M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ALERS Stock
  4. Financials Eurobio Scientific